alexa LC-MS/MS Bioanalysis Method Development, Validation, and Sample Analysis: Points to Consider When Conducting Nonclinical and Clinical Studies in Accordance with Current Regulatory Guidances | Abstract
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

LC-MS/MS Bioanalysis Method Development, Validation, and Sample Analysis: Points to Consider When Conducting Nonclinical and Clinical Studies in Accordance with Current Regulatory Guidances

Monica Whitmire1,3*, Jennifer Ammerman2, Patricia de Lisio2, Jacqueline Killmer1, Devon Kyle2, Emily Mainstone1, Lynann Porter2 and Tianyi Zhang1

1MPI Research, 54943 North Main Street, Mattawan, Michigan 49071, USA

2MPI Research, 3058 Research Drive, State College, Pennsylvania 16801, USA

3MPI Research; 54943 North Main Street, Mattawan, MI 49071, USA

*Corresponding Author:
Dr. Monica Whitmire
Study Director, MPI Research
54943 North Main Street, Mattawan, MI 49071, USA
Tel: 1.269.668.3336, ext. 3138
E-mail: [email protected]

Received date: May 21, 2011; Accepted date: July 25, 2011; Published date: Augutst 05, 2011

Citation: Whitmire M, Ammerman J, de Lisio P, Killmer J, Kyle D (2011) LC-MS/ MS Bioanalysis Method Development, Validation, and Sample Analysis: Points to Consider When Conducting Nonclinical and Clinical Studies in Accordance with Current Regulatory Guidances. J Anal Bioanal Tech S4:001. doi: 10.4172/2155-9872.S4-001

Copyright: © 2011 Whitmire M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Recently, there has been a heightened public awareness of drug safety across the globe. Nonclinical and clinical pharmacokinetic and toxicokinetic toxicology safety studies all require that the study samples be analyzed under the auspices of good laboratory practice (GLP) standards. GLPs are followed in order to ensure that safety studies are reliable and accurate. Several countries have issued or are in the process of issuing their own versions of bioanalytical guidance documents for performing method validation activities; however, each one is slightly different. These differences often make complying with regulatory requirements difficult and cumbersome. Several networking organizations have been working diligently to harmonize the various global bioanalytical guidance documents. This paper attempts to shed light on some of the critical points to consider when performing bioanalytical method development and GLP compliant validation activities from a scientist’s perspective.

Keywords

Recommended Conferences
Share This Page
Top